Positive Retail Rental Reversion and Strong Tenant Sales Momentum in 1Q FY2027

 

Key Highlights

• Positive retail rental reversion of 10.0%¹ achieved for 1Q FY2027.
• Portfolio committed occupancy remained healthy at 94.4%², with a strong retail portfolio committed occupancy of 98.2%.
• Tenant sales grew 45.5% year-on-year (“YoY”) in 1Q FY2027. On a like‑for‑like basis, excluding PLQ Mall, tenant sales increased by 8.1% YoY.
• Weighted average cost of debt³ lowered to 2.50% per annum (vs. 2.75% per annum for FY2026).
• Reconfiguration of space at PLQ Mall is on track for completion by end-2026, with new tenants expected to enhance the mall's positioning and support income growth.
• Retained Regional Sector Leader (Asia Retail Listed) status in the GRESB 2026 Assessment for the seventh consecutive year and recognised as Global Sector Leader (Retail Listed) while maintaining a 5 Star rating.

SINGAPORE, Nov 2 (Bernama-GLOBE NEWSWIRE) -- Lendlease Global Commercial Trust Management Pte. Ltd. (the “Manager”), the manager of Lendlease Global Commercial REIT (“Lendlease REIT”), announces its first quarter business updates for FY2027.

Operational Performance

As of 30 September 2026, Lendlease REIT’s portfolio committed occupancy stood at a healthy 94.4%². The retail portfolio remained close to full occupancy at 98.2%, easing slightly from 98.5% in the prior quarter. This was mainly due to temporary vacancies from the ongoing space reconfiguration works at PLQ Mall.

The portfolio’s weighted average lease expiry (“WALE”) remained healthy at 4.4 years by net lettable area (“NLA”) and 3.4 years by gross rental income (“GRI”), underpinned by a well-spread lease expiry profile with only 4.8% of NLA and 7.7% by GRI due for renewal in FY2027.

Positive Retail Rental Reversion and Strong Tenant Sales Momentum

Lendlease REIT’s retail portfolio achieved a positive rental reversion of 10.0%¹ for 1Q FY2027. Visitation and tenant sales grew 27.4% and 45.5% YoY respectively, mainly driven by the inclusion of PLQ Mall for the full quarter. Excluding PLQ Mall, like-for-like visitation and tenant sales increased 6.7% and 8.1% YoY respectively.

During the quarter, Lendlease REIT continued to strengthen its retail offering by welcoming new-to-portfolio and new-to-market tenants, including Gentlewomen and LSOUL at 313@somerset, heytea and PastaGo at PLQ Mall and Setirom at Jem. These additions are expected to support footfall across the portfolio.

The reconfiguration of approximately 16,000 sq ft of space at PLQ Mall remains on track for completion by end-2026, with new tenants expected to enhance the mall's positioning and support income growth.

Capital Management

Reduced Cost of Debt

As of 30 September 2026, gross borrowings stood at S$1,679.9 million, with gearing lowered to 38.7% from 38.9% as of 30 June 2026.

The weighted average cost of debt³ improved to 2.50% per annum, from 2.75% per annum reported for FY2026, attributed mainly to the loans associated with PLQ Mall that were refinanced at a lower cost of borrowing. As at 30 September 2026, approximately 68% of Lendlease REIT’s borrowings are hedged to fixed rates.  

The interest coverage ratio ("ICR")⁴ remained healthy at 2.1 times⁵, with the benefits of the lower blended cost of funding from the June 2026 perpetual securities refinancing set to accrue progressively over time.

Mr. Guy Cawthra, Chief Executive Officer of the Manager, said, "Despite ongoing global uncertainty and macroeconomic headwinds, we are encouraged by our strong start to FY2027. Our portfolio has demonstrated resilience, underpinned by healthy leasing momentum and continued execution of our capital management initiatives. We look to build on this momentum in the quarters ahead, supported by the full-period contribution from PLQ Mall and the positive rental reversions secured over the past year."

Award and Recognition

Global Sector Leader and Regional Sector Leader in the Retail category

In the GRESB 2026 Assessment, Lendlease REIT retained its title as Regional Sector Leader (Asia Retail Listed) for the seventh consecutive year, ranking first across all peer groups with a score of 96.6, well above the GRESB average of 80.9. Lendlease REIT was also recognised as the Global Sector Leader (Retail Listed), underscoring its sustainability leadership on a global scale.

Separately, Lendlease and Lendlease REIT received the Impact Enterprise Excellence Award (Large Enterprise) at the Sustainability Impact Awards 2026, in recognition of the strength of its sustainability strategy and its positive environmental and social impact.

About Lendlease Global Commercial REIT

Listed on 2 October 2019, Lendlease Global Commercial REIT (“Lendlease REIT”) is established with the principal investment strategy of investing, directly or indirectly, in a diversified portfolio of stabilised income-producing real estate assets located globally, which are used primarily for retail and/or office purposes.

As at 30 June 2026, its portfolio comprises leasehold properties in Singapore namely Jem (retail) (a suburban retail property), 313@somerset (a prime retail property), PLQ Mall (a suburban retail property) as well as freehold interest in three Grade A commercial buildings in Milan. These properties have a total value of approximately S$4.2 billion. Other investments include a stake in Parkway Parade (an office and retail property) and development of Grange House (a multifunctional event space) adjacent to 313@somerset.

Lendlease REIT is managed by Lendlease Global Commercial Trust Management Pte. Ltd., an indirect wholly-owned subsidiary of Lendlease Corporation Limited.

About the Sponsor - Lendlease Corporation Limited

Lendlease is an international real estate group listed on the Australian Securities Exchange. Their core capabilities are reflected in their operating segments of Investments, Development and Construction. Lendlease draws on this expertise to realise opportunities that create real value and returns for their partners and customers, as well as the communities who experience the places they shape. For more information, please visit: www.lendlease.com.

For more information on Lendlease REIT, please contact Investor Relations:

Lendlease Global Commercial Trust Management Pte. Ltd.
Ling Bee Lin
enquiry@lendleaseglobalcommercialreit.com
Tel: +65 6671 7374

Important Notice

This press release is for information purposes only and does not constitute or form part of an offer, invitation or solicitation of any offer to purchase or subscribe for any securities of Lendlease Global Commercial REIT (“Lendlease REIT”) in Singapore or any other jurisdiction nor should it or any part of it form the basis of, or be relied upon in connection with, any contract or commitment whatsoever.

The value of units in Lendlease REIT (the “Units”) and the income derived from them may fall as well as rise. Units are not obligations of, deposits in, or guaranteed by Lendlease Global Commercial Trust Management Pte. Ltd. (the “Manager”), DBS Trustee Limited (as trustee of Lendlease REIT) or any of their affiliates.

This press release may contain forward-looking statements that involve risks and uncertainties. Actual future performance, outcomes and results may differ materially from those expressed in forward-looking statements as a result of a number of risks, uncertainties and assumptions. Representative examples of these factors include (without limitation) general industry and economic conditions, interest rate trends, cost of capital and capital availability, competition from similar developments, shifts in expected levels of property rental income, changes in operating expenses, (including employee wages, benefits and training costs), property expenses and governmental and public policy changes and the continued availability of financing in the amounts and the terms necessary to support future business.

An investment in Units is subject to investment risks, including the possible loss of the principal amount invested. Holders of Units (“Unitholder”) have no right to request the Manager to redeem or purchase their Units while the Units are listed. It is intended that Unitholders may only deal in their Units through trading on Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing of the Units on SGX-ST does not guarantee a liquid market for the Units.

This press release is not to be distributed or circulated outside of Singapore. Any failure to comply with this restriction may constitute a violation of United State securities laws or the laws of any other jurisdiction.

The past performance of Lendlease REIT is not necessarily indicative of its future performance.
_______________________
_{¹ Year-to-date as at 30 September 2026, comparing the weighted average rent of outgoing and incoming leases.
² Lettable area for Milan assets is based on latest valuation report.
³ Excludes amortisation of debt-related transaction costs.
⁴ Calculation is in accordance with the Property Funds Appendix of the Code on Collective Investment Schemes (“PFA”). The ICR in accordance with loan agreements exceeds 4.0 times, in excess of debt covenant at 2.0 times.
⁵ Per the PFA, calculation is based on a trailing 12 months period ending on the date of the latest reported financial results. ICR as at both 30 September 2026 and 30 June 2026 is based on the last reported financial results as at 30 June 2026.} 


SOURCE: DBS Trustee Limited as Trustee of Lendlease Global Commercial REIT (“LREIT”)

EUROPEAN DEEP-TECH FIRMS SEEK SINGAPORE INVESTORS AT INNOVATION NIGHT

KUALA LUMPUR, Oct 29 (Bernama) -- More than 150 investors, corporate leaders, policymakers and innovators met European deep-tech companies at the European Innovation Night in Singapore on Oct 28, an event aimed at building business and investment partnerships between Europe and Singapore.

According to the European Innovation Council (EIC) in a statement, Singapore is the second-largest source of investment in EIC-backed companies outside Europe, after the United States.

“Singapore is a strategic partner for the EIC, with strong investment ties to our portfolio and shared ambitions for innovation, competitiveness and sustainable growth,” said EIC Head of Department, Stéphane Ouaki.

More than 60 European start-ups and scale-ups attended, including 12 backed by the EIC, and are meeting Singaporean investors and corporates to explore partnerships, co-development, supply chain integration and investment, throughout the week.

National Research Foundation Singapore Chairman, Heng Swee Keat said Singapore serves as a trusted hub for companies to test, validate and scale new solutions in Asia and beyond, complementing Europe’s scientific and engineering strengths.

EIC-backed scale-ups have raised 15.5 billion euros to date, with more than 1,000 investors co-investing alongside the EIC. The portfolio has produced 12 unicorns, and 2025 was its most active year, with over 500 million euros invested across 130-plus transactions. (1 Euro = RM4.54)

The event was co-organised by the EIC, the European Union (EU) Delegation to Singapore and the Eureka which brought a delegation of 35 companies from 16 countries. It was held at the Asian Civilisations Museum during the Singapore International Energy Week and SWITCH, the Singapore Week of Innovation and Technology.

-- BERNAMA

Ras Al Khaimah Signs Landmark Friendship Agreement & 10 MoUs during Historic High-Level Tour of South China

 

^{His Highness Sheikh Saud bin Saqr Al Qasimi, UAE Supreme Council Member and Ruler of Ras Al Khaimah, witnessed the signing of a landmark agreement between Ras Al Khaimah and Fujian Province, alongside 10 Memoranda of Understanding between entities from the Emirate and their Chinese counterparts, reflecting a shared commitment to broadening cooperation and translating longstanding relations into meaningful opportunities for the future. (Photo: AETOSWire)} 


RAS AL KHAIMAH, United Arab Emirates, Oct 29 (Bernama-BUSINESS WIRE) -- His Highness Sheikh Saud bin Saqr Al Qasimi, UAE Supreme Council Member and Ruler of Ras Al Khaimah, witnesses the signing of a historic agreement between Ras Al Khaimah and Fujian Province, China, concluding a six-day China visit.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261028878989/en/ 

Signed in Fuzhou, the agreement establishes a framework for strengthening economic, maritime and cultural ties, including cooperation in green supply chains, port logistics, sustainable building materials and cultural exchange.

Commenting on the agreement, HH Sheikh Saud said: “The friendship between Ras Al Khaimah and China is deeply rooted in history and revitalized by a shared vision for modern economic transformation. Signing this friendship agreement with Fujian Province cements a partnership rooted in mutual respect, shared ambition and centuries of maritime connection, which creates a formal foundation for our communities and enterprises to collaborate more closely.”

The friendship agreement followed the signing of 10 MoUs between Ras Al Khaimah entities and Chinese counterparts, all witnessed by HH Sheikh Saud. These included a MoU between the Government of Ras Al Khaimah’s International Relations Office and UBTECH Robotics to test, demonstrate and deploy humanoid robotic systems across industrial, commercial service, elderly care and cultural tourism sectors.

Other MoUs were signed between RAK Transport Authority and Shenzhen Urban Transport Planning Center; separate agreements involving Marjan Group and RAKBANK and the Bank of China (Dubai Branch); the International Relations Office and Phoenix New Media Information Technology; Marjan Group and China Road and Bridge Corporation; Ras Al Khaimah Chamber of Commerce and Industry (RAK Chamber) and Tianhe Central Business District; RAK Chamber and the Bureau of China International SME Fair; Ras Al Khaimah Department of Antiquities & Museums and Sun Yat-sen University History Museum; and Ras Al Khaimah Economic Zone (RAKEZ) and Fujian Jihong Packaging Technology.

The visit, from October 18 to 23, covered Shenzhen and Guangzhou in Guangdong Province, and Fuzhou in Fujian Province. It included the RAK-China Business Conference, high-level meetings with government officials and business leaders, and the inauguration of Ras Al Khaimah’s first business consultancy in China, in Guangzhou.

These engagements build on Ras Al Khaimah’s longstanding relationship with China, rooted in centuries of maritime trade and cultural exchange, and reflect a shared commitment to strengthening economic, investment and cultural cooperation.

*Source: AETOSWire

View source version on businesswire.com:
https://www.businesswire.com/news/home/20261028878989/en/

Contact

Steven McCombe
media@rakmediaoffice.ae

Source : RAK Media Office

HACK THE BOX CYBER TRAINING YIELDS 330 PCT ROI - STUDY

KUALA LUMPUR, Oct 28 (Bernama) -- A study commissioned by cybersecurity training platform Hack The Box (HTB) and conducted by Forrester Consulting has found that a modelled organisation using the platform achieved a 330 per cent return on investment over three years, recouping its costs in less than six months.

The study, Total Economic Impact, is based on interviews with seven decision-makers at HTB customers in the financial services, government, technology and professional services sectors. Their experiences were combined into a single composite organisation with a cybersecurity workforce of over 300 people, and the financial figures are risk-adjusted present values.

“The question we hear most often is how many cybersecurity jobs AI will replace. The more important question is whether teams are prepared to use AI effectively,” said HTB chief executive officer and founder, Haris Pylarinos.

In a statement, he said artificial intelligence (AI) amplifies the capabilities of the people using it, which is why workforce readiness matters.

Over three years, the composite organisation realised US$1.2 million in benefits against US$285,000 in costs, giving a net present value of US$939,000. (US$1 = RM4.08)

The study found a 50 per cent reduction in the probability of security incidents escalating, linked to earlier threat detection and attackers spending less time inside systems undetected. Incident response teams cut the time taken to acknowledge incidents by 50 per cent and the time to resolve them by 30 per cent.

Onboarding efficiency improved by 35 per cent and penetration testing efficiency by 50 per cent. Workforce attrition fell by four per cent, while annual cybersecurity certifications rose by 20 per cent.

Forrester Research separately named HTB a Leader in its Forrester Wave report on cybersecurity skills and training platforms for the first quarter of 2026, giving it the highest possible scores in 13 criteria, including readiness for agentic AI.

-- BERNAMA

Bitget Upgrades Stock Dual Investment with VETA Finance for Tokenized U.S. Equities

VICTORIA, Seychelles, Oct 27 (Bernama-GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), has upgraded Stock Dual Investment, expanding its structured investment offerings to tokenized U.S. Equities through a partnership with VETA Finance. The launch introduces new stock-linked underlying assets and maturity options, allowing users to earn fixed-term yields while executing predefined strategies based on market conditions.

Stock Dual Investment lets users earn yield on USDT or eligible tokenized U.S. Equities over a fixed investment period, with settlement determined by a predefined target price and the assets's market performance at maturity. Current underlying assets include rNVDA, rGOOGL and rAMD, providing exposure to tokenized equities linked to NVIDIA, Alphabet, and AMD.

Buy Low allows users to subscribe with USDT and pick a target price for an eligible rToken. If the settlement price at maturity is at or below the target price, the investment is converted into the corresponding rToken at the predetermined price. Otherwise, users receive their principal and accrued yield in USDT. This strategy is designed for users looking to accumulate tokenized equities at a chosen price while earning yield during the investment period.

Sell High allows users to subscribe with an eligible rToken and pick a target price to sell. If the settlement price at maturity is at or above the target price, the investment is converted into USDT at a predetermined price. Otherwise, users retain their rToken principal and receive the applicable yield. This strategy is designed for holders waiting to sell at a selected price while earning yield on their existing positions.

"Investors often have a price in mind at which they would buy more or take profits. Stock Dual Investment, lets them earn yield while working toward those targets.That is our UEX vision of bringing crypto and traditional assets together with more ways to put them to work," said Gracy Chen, CEO of Bitget.

This product is offered in partnership with VETA Finance, a structured-product infrastructure provider focused on digital assets and tokenized markets. Since 2022, VETA Finance has provided end-to-end solutions for trading platforms, asset managers, and wealth-management providers, spanning product structuring, pricing, hedging, execution, and settlement.

Daniel Yu, Founder of VETA Finance, said: "Tokenization solved how equities get on-chain. Structured products solve how those assets are retained and how they generate yield. We are delighted to join Bitget's rToken ecosystem as a first-batch quoting vendor and bring the pricing, hedging and lifecycle management capabilities we have built in crypto structured products to tokenized US stocks in full. Dual Investment is only the first step. Together with Bitget, we intend to turn every tokenized US stock into a complete product line."

By extending Dual Investment to tokenized U.S equities, Bitget is bringing structured investment strategies traditionally associated with financial markets into its unified digital ecosystem. Users can deploy stablecoins or eligible rTokens through a single platform, creating additional opportunities to manage their exposure to tokenized equities without navigating separate trading environments. The launch further advances Bitget's Universal Exchange vision by expanding how users can access and utilize both crypto and tokenized traditional financial assets.

For more information, visit: https://www.bitget.com/support/articles/12560603898683

About VETA Finance

VETA Finance is an infrastructure provider for digital asset structured products. Since 2022 it has delivered end-to-end structured products services, from quoting and structuring to pricing, hedging and settlement, to leading trading platforms, asset managers and wealth channels. Its product range spans the full crypto structured products spectrum, including Dual Investment, Sharkfin, Snowball, Fixed Coupon Notes, Accumulators and Decumulators, Collars and zero-coupon lending, and the same product matrix is now being extended to tokenized US equities. VETA's proprietary structured products management system provides channels with one-stop RFQ, booking, settlement and lifecycle management, complemented by algorithmic execution services. The team combines investment banking, asset management and top-tier fund derivatives experience with years of live crypto trading.

About Bitget

Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 500+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships such as MotoGP™. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.

For more information, visit: Website | X | Telegram | LinkedIn | Discord

For media inquiries, please contact: media@bitget.com

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/7d711fee-6a0a-4325-a1a2-a229bf9e545c

SOURCE: Bitget Limited

DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.

--BERNAMA

GTCFX Appoints Charbel Raffoul as CEO, Strengthening Executive Leadership and Global Growth Strategy

DUBAI, United Arab Emirates, Oct 20 (Bernama-GLOBE NEWSWIRE) -- GTCFX is pleased to announce the appointment of Charbel Raffoul as Chief Executive Officer (CEO), marking an important milestone in the company's continued development and commitment to operational excellence, strong leadership, and international growth.

With nearly two decades of experience in the financial services industry, Charbel brings extensive expertise in corporate governance, regulatory compliance, financial operations, and strategic management. His appointment further strengthens GTCFX's executive leadership team as the company advances its long-term strategic objectives and expands its capabilities across global financial markets.

Extensive Experience Across Leading Financial Institutions 

Prior to joining GTCFX, Charbel served as Chief Compliance Officer & Financial Crime at Equiti, where he spent more than eight years contributing to the advancement of compliance frameworks, compliance risk management, and regulatory practices. 

His professional career also includes senior positions at several established financial institutions, including Director at ADS Securities, Head of Compliance at Alpari ME, and Back Office Manager at Swissquote. 

Throughout his career, Charbel has developed valuable expertise in financial services operations, regulatory oversight, risk management, and organizational governance. His experience across multiple areas of the industry provides a strong foundation for leading GTCFX and supporting its continued development. 

Advancing GTCFX's Global Vision 

As Chief Executive Officer, Charbel will guide GTCFX's strategic direction, focusing on strengthening operational capabilities, advancing innovation, enhancing corporate governance, and supporting international business development.

His leadership will contribute to the company's ongoing efforts to improve operational efficiency, strengthen relationships with clients and partners, and deliver long-term value through professional services and responsible business practices.

Combining his extensive industry knowledge with a strong understanding of regulatory and operational standards, Charbel brings a valuable perspective to GTCFX's continued evolution in the global financial services sector.

His appointment reflects GTCFX's commitment to building an experienced leadership team capable of supporting the company's strategic ambitions while maintaining high standards of professionalism, integrity, and transparency.

Building on Experience, Moving Forward with Confidence

As GTCFX continues to develop its international presence and strengthen its organizational capabilities, experienced executive leadership remains central to its long-term vision.

Charbel's professional background, industry knowledge, and management experience will play an important role in supporting the company's next stage of development.

GTCFX warmly welcomes Charbel Raffoul as Chief Executive Officer and looks forward to his leadership in shaping a new chapter of innovation, progress, and sustainable global growth.

Media Contact

Email: support@gtcprime.com

Website: https://www.gtcfx.com/en-intl

A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/e9e2d81d-f5b1-4d75-bff7-553941739bf6

SOURCE: GTC Global Trade Capital Co. Limited 

DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.

--BERNAMA 

Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia


Highlights

• Collaboration aims to accelerate precision oncology research in Australia
• Combines Fortrea’s experience in oncology clinical trials with Omico’s Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program
• Together, Fortrea and Omico offer more efficient investigator site selection and faster patient access by connecting patients with relevant biomarker-driven clinical trials
   

DURHAM, N.C. and SYDNEY, Oct 23 (Bernama-GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), and Omico, Australia’s leading precision oncology screening and trial matching organization, today announced a collaboration to accelerate precision oncology research by helping connect cancer patients to biomarker-matched clinical trials. By combining Omico's precision oncology network with Fortrea's scientific and clinical trial experience, the joint effort aims to improve study planning, site selection and patient recruitment to expand access to biomarker-driven oncology research globally.

Through this initiative, Omico will support Fortrea’s clients in their oncology drug development needs by providing access to patient population insights, including genomic profiling, trial-matching capabilities, real-world oncology data and patient referral pathways in Australia, a key country both for early and late phase Oncology clinical research activities. The collaboration will combine Fortrea’s oncology drug development experience with Omico’s flagship Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program, the largest cancer genomics initiative in Australia. PrOSPeCT is designed to provide molecular profiling and help match patients to biomarker-driven clinical trials and targeted therapies.

“Our collaboration with Omico is about seeking to reach the right patient for the right study as quickly as possible,” said Oren Cohen, M.D., Chief Medical Officer at Fortrea. “Modern oncology development demands ever-greater precision to match specific cancers with the therapies most likely to benefit patients, and to do so as quickly as possible. Our work with Omico accelerates our ability to identify the right patients for biomarker-driven studies in Australia and help advance precision medicine for people with cancer.”

Omico has built one of Australia's most extensive precision oncology ecosystems, combining molecular profiling, real-world evidence, cohort research programs and a nationwide network of investigators and clinical sites. Omico has reported more than 23,000 consented patients within its clinic-genomic databases and has received referrals from more than 1,600 clinicians across Australia.

“Australia is well positioned to support global biomarker-driven clinical trials, through Omico’s established national precision oncology research infrastructure, expertise and networks,” said Professor David Thomas, Chief Science and Strategy Officer at Omico. “By combining our national data and trial matching capabilities with Fortrea’s global clinical development expertise, we can help international sponsors identify relevant patient populations, plan trials more effectively and support targeted recruitment.”

Fortrea’s oncology expertise is underpinned by thousands of operational professionals and supported by more than 50 oncology physicians on staff. This collaboration comes at a time when modern oncology drug development has accelerated the focus on precision medicine, biomarker-driven development and targeted patient identification. Working together, Fortrea and Omico can offer more efficient site selection and the ability to match patients with appropriate studies tied to their unique genomic data, enabling more people to participate in studies tailored to their specific condition in Australia.

About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn and X and Bluesky.

About Omico
Omico is an independent, national, not-for-profit research organisation changing the way we fight cancer. We work to improve outcomes for Australians with cancer by providing equitable access to precision oncology and translating scientific advances into clinical care and research, and generating the evidence needed to inform health policy and system reform. Working with Australia's leading cancer institutes, researchers, clinicians, industry partners, advocacy groups and government, we are accelerating molecular profiling, biomarker-led clinical trials, personalised cancer risk management and real-world evidence.

About PrOSPeCT
PrOSPeCT is Australia's largest precision oncology initiative. Delivered by Omico and a national network of healthcare, research and industry partners, it provides eligible Australians with access to molecular profiling and matching to biomarker-led clinical trials and therapies (at no cost to the patient), while generating clinical, genomic, treatment and outcomes data to advance research, improve cancer care and inform future health policy.

Fortrea Contacts:
Galen Wilson (Media) – 703-298-0802, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
Tracy Krumme (Investors) – 984-385-6707, Tracy.Krumme@fortrea.com

Omico Contact:
Kym Bramich (Communications) – +61 414 795 087, k.bramich@omico.org.au 

SOURCE: Fortrea Holdings Inc